Doctor Roni Nielsen

Aarhus University Hospital, Aarhus (Denmark)

Contributor content

Presentation

Cardiovascular and metabolic effects of treatment with the ketone body 3-hydroxybutyrate in patients with chronic heart failure.

Presentation

The effect of liraglutide on natriuretic peptides and copeptin in heart failure patients

Presentation

The ketone body 3-hydroxybutyrate increases cardiac output without affecting myocardial external efficiency

$The ketone body 3-hydroxybutyrate increases cardiac output and left ventricular contractile function in heart failure patients with reduced ejection fraction$

Presentation

The ketone body 3-hydroxybutyrate increases cardiac output and left ventricular contractile function in heart failure patients with reduced ejection fraction

Presentation

Quantitative estimation of extravascular lung water volume and preload by dynamic 15O-H2O positron emission tomography

Presentation

Effect of liraglutide on myocardial glucose uptake and blood flow in non-diabetic heart failure patients

Explore sponsored resources

Doctor Roni Nielsen

Contributor content

Cardiovascular and metabolic effects of treatment with the ketone body 3-hydroxybutyrate in patients with chronic heart failure.

The effect of liraglutide on natriuretic peptides and copeptin in heart failure patients

The ketone body 3-hydroxybutyrate increases cardiac output without affecting myocardial external efficiency

The ketone body 3-hydroxybutyrate increases cardiac output and left ventricular contractile function in heart failure patients with reduced ejection fraction

Quantitative estimation of extravascular lung water volume and preload by dynamic 15O-H2O positron emission tomography

Effect of liraglutide on myocardial glucose uptake and blood flow in non-diabetic heart failure patients

ESC 365 is supported by